This announcement is a separate document:
迪哲医药：普华永道中天会计师事务所（特殊普通合伙）关于迪哲（江苏）医药股份有限公司2023年度非经常性损益明细表专项报告
Dizal: PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) Special Report on the 2023 Non-Recurring Profit and Loss Statement of Digee (Jiangsu) Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated